PhysioMimix™ Multi-Organ Microphysiological System selected by The Scientist as a ‘Top 10 Innovation 2021′
- Date 1 Dec 2021
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), has been recognised by The Scientist for developing a Top 10 Innovation of 2021. This year’s list includes CN Bio’s PhysioMimix™ Multi-Organ MPS; a next-generation OOC platform that provides advanced insights into the potential effects of novel therapeutics that were previously only achievable using animal models.
Annually, the industry-leading publication, The Scientist, publishes a list of innovations and solutions that its panel of expert judges predict will have the largest impact in advancing scientific understanding and addressing key life sciences challenges. One such challenge is the inefficiency of drug discovery. With only one in ten candidates in phase I trials gaining market approval, there is an urgent need for human-relevant tools that deliver improved predictions of clinical success.
You might also be interested in these articles
Steaming up Success: ARU student’s path from café to creativity
We recently did a Q&A session with Anglia Ruskin student Soorya Jith, who started his journey as a Barista at the Lakeside Café within the Bradfield Centre on Cambridge Science Park. He has now transitioned to Krank, also located on the Park, as a Junior Graphic Designer.
Sun 21 Apr 2024
Cambridge Science Park
Cambridge Future Tech Expands its Board with the Appointment of Michael Beer and Jem Davies as Non-Executive Directors
Leading DeepTech Venture-Builder Further Strengthens its Unique Position to Cultivate Innovative Technologies with the Addition of Seasoned Industry Professionals
Sun 14 Apr 2024
Cambridge Future Tech
Xampla welcomes former P&G chemist to team as scale-up accelerates
accelerates CREATOR of plastic-free, natural materials, Xampla, continues to scale-up the commercialisation of its biodegradable Morro materials with new industry hire.
Fri 1 Mar 2024
Xampla Ltd
